Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine added to bupivacaine for TAP block after laparoscopic cholecystectomy
ACTRN12616001708448Phase 4Completed
- Sponsor
- Derya Karasu
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in postoperative pain comparing Bupivacaine TAP block control with Ketamine + bupivacaine TAP block (2 arms). Primary endpoints: Analgesic consumption during first 24 hours, Time to first analgesic requirement and 1 more. Started Dec 2016; status: completed.
02
Drugs
ketaminebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12616001708448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001708448.